2020
Inequalities in diagnosis and registration of pediatric very rare tumors: a European study on pleuropulmonary blastoma
GRIGOLETTO, V.; A. TAGARELLI; M. SPARBER-SAUER; E. KOSCIELNIAK; D. ORBACH et al.Základní údaje
Originální název
Inequalities in diagnosis and registration of pediatric very rare tumors: a European study on pleuropulmonary blastoma
Autoři
GRIGOLETTO, V.; A. TAGARELLI; M. SPARBER-SAUER; E. KOSCIELNIAK; D. ORBACH; M. DUPLAN; T. STACHOWICZ-STENCEL; E. BIEN; R. LOPEZ-ALMARAZ; T. BEN-AMI; A. POURTSIDIS; G. OSTERLUNDH; Pavel MAZÁNEK; J. ZSIROS; N. FARINHA; A. FERRARI a G. BISOGNO
Vydání
European journal of pediatrics, New York, Springer, 2020, 0340-6199
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30209 Paediatrics
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.183
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/20:00115983
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Childhood cancer; Rare tumors; Pleuropulmonary blastoma; Cancer registry
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 31. 8. 2020 12:13, Mgr. Tereza Miškechová
Anotace
V originále
Very rare tumors (VRTs) account for up to 11% of childhood cancers. Dedicated national groups and registries only exist in some European countries. Pleuropulmonary blastoma (PPB) is a very rare intrathoracic pediatric tumor with a potentially severe prognosis. Due to its rarity, it sometimes goes unrecognized. We investigated PPB diagnostic capability and possible correlations between diagnostic performance and VRT-dedicated activities. The number of cases of PPB registered between 2000 and 2014 at pediatric oncology centers in Europe was compared with the number of expected cases. Data sources included VRT registries, population-based cancer registries, and hospital registries. Data were obtained for 25 countries, grouped into 4 geographical regions. The expected cases were 111, and the observed cases were 129. The observed-to-expected ratio was 1.86 for Northern Europe, 1.33 for Southern Europe, 1.22 for Central Europe, and 0.65 for Eastern Europe. More cases than expected were registered in all countries with an official VRT registry. Conclusion: The number of cases observed is consistent with expectations, but disparities exist across Europe. Difficulties in diagnosing PPB emerged in most Eastern countries. The incidence rate of PPB may be underestimated. The creation of VRT-dedicated groups and a European Registry for VRTs could help to reduce inequalities.